Sellas Life Sciences Group Inc
NASDAQ:SLS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.9889
5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
SLS
stock under the Base Case scenario is
1.24
USD.
Compared to the current market price of 4.51 USD,
Sellas Life Sciences Group Inc
is
Overvalued by 72%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Sellas Life Sciences Group Inc.
Fundamental Analysis
SLS Profitability Score
Profitability Due Diligence
Score
SLS Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Sellas Life Sciences Group Inc
Balance Sheet Decomposition
Sellas Life Sciences Group Inc
Sellas Life Sciences Group Inc
Free Cash Flow Analysis
Sellas Life Sciences Group Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Sellas Life Sciences Group Inc
Wall St
Price Targets
SLS Price Targets Summary
Sellas Life Sciences Group Inc
According to Wall Street analysts, the average 1-year price target for
SLS
is 6.97 USD
with a low forecast of 6.06 USD and a high forecast of 7.88 USD.
Dividends
Current shareholder yield for
SLS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SLS
stock under the Base Case scenario is
1.24
USD.
Compared to the current market price of 4.51 USD,
Sellas Life Sciences Group Inc
is
Overvalued by 72%.